"DIABETIC FIBER" CAPTURES ATTENTION OF DIABETICS
Florida, April 8, 2020 April 8, 2020 -- InvestorsHub
NewsWire – This week on Bev Industry News: A new "diabetic"
nutritional fiber recognized by the Food & Drug Administration
(FDA) and shown in clinical data to slow the body's absorption of
sugar and improve overall blood sugar levels is just now finding
its way into products catering to America's millions of diabetics –
and in the process is creating a sizeable market opportunity for
top companies like Archer
Daniels Midland Co. (NYSE:ADM), Glucose
Health, Inc. (OTC: GLUC) Procter
& Gamble Co. (NYSE: PG), GlaxoSmithKline
PLC (NYSE: GSK) and even Tilray
Inc. (NASDAQ: TLRY).
According to the latest
2020 statistics compiled by the U.S. Centers for Disease Control
& Prevention (CDC), 34.2 million Americans are diagnosed
diabetics, with 90% having preventable, adult onset diabetes, also
known as Type-2. Four years ago, Archer Daniels Midland Co.
submitted dozens of clinical studies to the FDA concerning an
entirely new form of nutritional dietary fiber it was developing,
certain to find a market with America's growing diabetic
population. FDA issued new regulations with the effect that ADM's
dietary fiber can be referred to as such, finally paving the way
for introduction of new food and beverage products containing its
special fiber. According to MarketBeat.com, Stifel Nicolaus issued
an updated buy rating on ADM on April 1, 2020, with a $49 price
Among the first products to
reach retailer shelves utilizing ADM's innovative new fiber is
GlucoDown, made by Glucose Health, Inc. (OTC: GLUC). Using a special manufacturing process,
the company "agglomerates" ADM's fiber together with tea powder.
The result is America's first "healthy" diabetic iced tea.
GlucoDown quickly gained the attention of buyers at Walmart
and the product is now stocked at Walmart's superstores
nationwide. Not surprisingly, with iced tea the most popular
of all non-carbonated soft drinks and millions of diabetics to sell
to, Glucose Health, Inc. (OTC: GLUC) reported record revenues in its annual
report filing last month.
For decades, Procter and
Gamble's (NYSE: PG) Metamucil brand has helped consumers with what
P&G politely terms, "regularity". But it turns out the very
type of nutritional fiber used in Metamucil – psyllium – has also
shown similar positive effects on blood sugar metabolism as ADM's
fiber, in clinical research. The FDA has approved a qualified
health claim for psyllium, allowing the statement that the fiber
reduces the risk of Type-2 diabetes, but with the caveat that the
clinical data reported, is from relatively few studies. On March
30, Jefferies upgraded PG to a buy, according to
A third form of diabetic
fiber, found in Benefiber, manufactured by the consumer product arm
of pharmaceutical giant GlaxoSmithKline (NYSE: GSK), also has clinical data indicating
promising benefits related to blood sugar metabolism although no
health claims have yet been submitted to FDA. And now, even
CBD companies have gained a foothold in the market to serve
diabetic consumers. Tilray (NASDAQ: TLRY), one of the world's largest medical
cannabis suppliers, acquired start-up hemp fiber company Manitoba
Harvest last year, in a deal worth $317 million. CBD devotees
passionately advocate that hemp fiber has benefit for persons with
diabetes. However, to date, clinical studies and FDA applications
have yet to been undertaken.
For up-to-date news and
features on companies in the beverage industry, visit
National Diabetes Statistics Review, 2020;
Centers for Disease Control and Prevention, Department of Health
and Human Services.